These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases. Kawano-Dourado L; Kulkarni T; Ryerson CJ; Rivera-Ortega P; Baldi BG; Chaudhuri N; Funke-Chambour M; Hoffmann-Vold AM; Johannson KA; Khor YH; Montesi SB; Piccari L; Prosch H; Molina-Molina M; Sellares Torres J; Bauer-Ventura I; Rajan S; Jacob J; Richards D; Spencer LG; Wendelberger B; Jensen T; Quintana M; Kreuter M; Gordon AC; Martinez FJ; Kaminski N; Cornelius V; Lewis R; Adams W; Jenkins G; Thorax; 2024 Jul; 79(8):788-795. PubMed ID: 38448221 [TBL] [Abstract][Full Text] [Related]
6. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases. Salonen J; Purokivi M; Bloigu R; Kaarteenaho R BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195 [TBL] [Abstract][Full Text] [Related]
10. Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease. Goobie GC; Ryerson CJ; Johannson KA; Schikowski E; Zou RH; Khalil N; Marcoux V; Assayag D; Manganas H; Fisher JH; Kolb MRJ; Gibson KF; Kass DJ; Zhang Y; Lindell KO; Nouraie SM Am J Respir Crit Care Med; 2022 Feb; 205(4):459-467. PubMed ID: 34818133 [No Abstract] [Full Text] [Related]
11. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype. Takei R; Brown KK; Yamano Y; Kataoka K; Yokoyama T; Matsuda T; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Goto Y; Kondoh Y Respirology; 2022 May; 27(5):333-340. PubMed ID: 35293077 [TBL] [Abstract][Full Text] [Related]
12. Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease. Goobie GC; Carlsten C; Johannson KA; Khalil N; Marcoux V; Assayag D; Manganas H; Fisher JH; Kolb MRJ; Lindell KO; Fabisiak JP; Chen X; Gibson KF; Zhang Y; Kass DJ; Ryerson CJ; Nouraie SM JAMA Intern Med; 2022 Dec; 182(12):1248-1259. PubMed ID: 36251286 [TBL] [Abstract][Full Text] [Related]
13. Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease. Pillai M; Olson AL; Huie TJ; Solomon JJ; Fernandez-Perez ER; Brown KK; Hanna P; Lee-Chiong T; Swigris JJ Respir Med; 2012 Jul; 106(7):1033-9. PubMed ID: 22521226 [TBL] [Abstract][Full Text] [Related]
14. Pathology, Radiology, and Genetics of Interstitial Lung Disease in Patients With Shortened Telomeres. Cecchini MJ; Tarmey T; Ferreira A; Mangaonkar AA; Ferrer A; Patnaik MM; Wylam ME; Jenkins SM; Spears GM; Yi ES; Hartman TE; Scott JP; Roden AC Am J Surg Pathol; 2021 Jul; 45(7):871-884. PubMed ID: 33935155 [TBL] [Abstract][Full Text] [Related]
15. The role of the adenosinergic system in lung fibrosis. Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158 [TBL] [Abstract][Full Text] [Related]
16. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease. Valenzi E; Tabib T; Papazoglou A; Sembrat J; Trejo Bittar HE; Rojas M; Lafyatis R Front Immunol; 2021; 12():595811. PubMed ID: 33859634 [TBL] [Abstract][Full Text] [Related]
17. Interstital lung disease in ANCA vasculitis. Alba MA; Flores-Suárez LF; Henderson AG; Xiao H; Hu P; Nachman PH; Falk RJ; Charles Jennette J Autoimmun Rev; 2017 Jul; 16(7):722-729. PubMed ID: 28479484 [TBL] [Abstract][Full Text] [Related]
18. HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia. Amenomori M; Mukae H; Sakamoto N; Kakugawa T; Hayashi T; Hara A; Hara S; Fujita H; Ishimoto H; Ishimatsu Y; Nagayasu T; Kohno S Respir Med; 2010 Jun; 104(6):895-901. PubMed ID: 20129768 [TBL] [Abstract][Full Text] [Related]